-
REPORT PROLOGUE
-
MARKET INTRODUCTION
-
INTRODUCTION 17
-
SCOPE OF STUDY 17
-
RESEARCH OBJECTIVE 17
- ASSUMPTIONS 18
-
2.4
-
ASSUMPTIONS & LIMITATIONS 18
-
2.4.2
-
LIMITATIONS 18
-
MARKET STRUCTURE 19
-
RESEARCH METHODOLOGY: HALITOSIS
-
MARKET
-
RESEARCH PROCESS 20
-
MARKET SIZE ESTIMATION 22
- MARKET SHARE ANALYSIS 23
-
FORECAST MODEL 24
-
MARKER
-
DYNAMICS
-
DRIVERS 25
- RISING PREVALENCE OF PERIODONTAL DISEASES
- GERIATRIC POPULATION 25
- AVAILABILITY OF WIDE
- INCREASING PREVALENCE OF CHRONIC DISEASES
-
25
-
RANGE OF PRODUCTS 25
-
25
-
RESTRAINTS 26
- LACK OF AWARENESS ABOUT HALITOSIS
- ALTERNATIVE TREATMENT 26
-
AND ITS TREATMENT 26
-
OPPORTUNITIES
- TECHNOLOGICAL ADVANCEMENT 26
-
26
-
MEGA TRENDS 26
- SHIFT FROM DIAGNOSIS TO MANAGEMENT 26
- NANO SENSOR
-
FOR DISEASE DIAGNOSIS 27
-
MACROECONOMIC INDICATORS 27
-
MARKET
-
FACTOR ANALYSIS
-
PORTER’S FIVE FORCES MODEL 28
- BARGAINING
- BARGAINING POWER OF BUYERS 29
- THREAT OF SUBSTITUTES 29
-
POWER OF SUPPLIERS 29
-
5.1.3
-
THREAT OF NEW ENTRANTS 29
-
5.1.5
-
INTENSITY OF RIVALRY 29
-
VALUE CHAIN ANALYSIS 30
- MANUFACTURING 30
- DISTRIBUTION &
- POST-SALES SERVICES 31
-
5.2.1
-
R&D 30
-
SALES 31
-
PRICING ANALYSIS
-
32
-
INVESTMENT OPPORTUNITY ANALYSIS 33
-
HALITOSIS TREATMENT
-
MARKET, BY TYPE
-
INTRODUCTION 34
-
PATHOLOGIC HALITOSIS 36
-
OTHER HALITOSIS 37
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
INTRODUCTION 38
-
RESPIRATORY DISORDERS 39
-
LIVER
-
DISORDERS 41
-
KIDNEY DISORDER 42
-
GASTROINTESTINAL DISORDERS
-
43
-
SYSTEMIC DISORDERS 44
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC
-
TEST
-
INTRODUCTION 45
-
HALIMETER 46
-
GAS CHROMATOGRAPHY
-
47
-
BANA TEST 48
-
B- GALACTOSIDASE ACTIVITY ASSAY 49
-
OTHER TESTS 50
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
INTRODUCTION 51
-
ANTACIDS 53
-
ANTISEPTICS 54
-
RANITIDINE 55
-
OTHER TREATMENTS 56
-
GLOBAL HALITOSIS
-
TREATMENT MARKET, BY REGION
-
INTRODUCTION 57
-
AMERICAS 58
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET,
-
BY DRUG TREATMENT
-
HALITOSIS TREATMENT MARKET, BY
-
TYPE
-
U.S. 63
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET,
-
BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
10.2.2
-
CANADA 66
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET,
-
BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS
-
TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
SOUTH AMERICA 69
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
EUROPE 73
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT
-
MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS
-
TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
GERMANY 77
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
FRANCE 80
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS
-
TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
UK 83
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
ITALY 86
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS
-
TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
SPAIN 89
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
EASTERN EUROPE 92
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS
-
TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
ASIA PACIFIC 96
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET,
-
BY DRUG TREATMENT
-
HALITOSIS TREATMENT MARKET, BY
-
TYPE
-
JAPAN 100
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET,
-
BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
10.4.2
-
CHINA 103
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET,
-
BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS
-
TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS TREATMENT
-
INDIA 106
-
MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT
-
MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
AUSTRALIA 109
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS
-
TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
112
-
REPUBLIC OF KOREA
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY
-
INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT
-
MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
REST OF ASIA PACIFIC 115
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
MIDDLE EAST & AFRICA 118
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY
-
DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
10.5.1
-
MIDDLE EAST 122
-
HALITOSIS TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT
-
MARKET, BY INDICATION
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS
-
TREATMENT MARKET, BY DRUG TREATMENT
-
HALITOSIS
-
AFRICA 125
-
TREATMENT MARKET, BY TYPE
-
HALITOSIS TREATMENT MARKET, BY INDICATION
-
HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST
-
HALITOSIS TREATMENT MARKET, BY DRUG TREATMENT
-
COMPETITIVE LANDSCAPE
-
INTRODUCTION 129
-
COMPANY SHARE
-
ANALYSIS 130
-
ABBOTT 131
- COMPANY OVERVIEW 131
- PRODUCT/BUSINESS SEGMENT OVERVIEW 131
- FINANCIAL
- KEY DEVELOPMENTS 133
- SWOT ANALYSIS
-
UPDATES 131
-
133
-
ALL USA PARTNERS LLC 134
- COMPANY OVERVIEW
- PRODUCT/BUSINESS SEGMENT OVERVIEW 134
- FINANCIAL
- KEY DEVELOPMENTS 134
- SWOT ANALYSIS
-
134
-
UPDATES 134
-
135
-
ASTRAZENECA 136
- COMPANY OVERVIEW 136
- PRODUCT/BUSINESS SEGMENT OVERVIEW 136
- FINANCIAL OVERVIEW
- KEY DEVELOPMENT 137
- SWOT ANALYSIS 138
-
136
-
COLGATE-PALMOLIVE COMPANY 139
- COMPANY OVERVIEW 139
- PRODUCT/BUSINESS SEGMENT OVERVIEW 139
- FINANCIAL
- KEY DEVELOPMENTS 140
- SWOT ANALYSIS
-
UPDATES 139
-
141
-
DR. HAROLD KATZ, LLC 142
- COMPANY OVERVIEW
- PRODUCT/BUSINESS SEGMENT OVERVIEW 142
- FINANCIAL
- KEY DEVELOPMENTS 142
- SWOT ANALYSIS
-
142
-
UPDATES 142
-
143
-
LISTERINE (PART OF JOHNSON & JOHNSON) 144
- PRODUCT/BUSINESS SEGMENT OVERVIEW 144
- FINANCIAL UPDATES 144
- KEY DEVELOPMENTS 145
- SWOT ANALYSIS 146
-
11.8.1
-
COMPANY OVERVIEW 144
-
ROWPAR PHARMACEUTICALS, INC. 147
- COMPANY OVERVIEW 147
- PRODUCT/BUSINESS SEGMENT OVERVIEW
- FINANCIAL UPDATES 147
- KEY DEVELOPMENTS 147
- SWOT ANALYSIS 148
-
147
-
MRFR CONCLUSION
-
KEY FINDINGS
- FROM CEO’S VIEW POINT 149
- UNMET NEEDS
-
149
-
149
-
KEY COMPANIES TO WATCH 149
-
APPENDIX
-
DISCUSSION
-
BLUE PRINT 150
-
REFERENCES 152
-
List of Tables
-
TABLE
-
GLOBAL HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 34
-
GLOBAL HALITOSIS TREATMENT MARKET FOR PATHOLOGIC HALITOSIS, BY REGION,
-
GLOBAL HALITOSIS TREATMENT MARKET
-
FOR OTHER HALITOSIS, BY REGION, 2023-2030 (USD MILLION) 37
-
GLOBAL
-
HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION) 38
-
TABLE
-
GLOBAL HALITOSIS TREATMENT MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023-2030
-
(USD MILLION) 40
-
GLOBAL HALITOSIS TREATMENT MARKET FOR LIVER
-
DISORDERS, BY REGION, 2023-2030 (USD MILLION) 41
-
GLOBAL HALITOSIS
-
TREATMENT MARKET FOR KIDNEY DISORDER, BY REGION, 2023-2030 (USD MILLION) 42
-
GLOBAL HALITOSIS TREATMENT MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION,
-
GLOBAL HALITOSIS TREATMENT MARKET
-
FOR SYSTEMIC DISORDERS, BY REGION, 2023-2030 (USD MILLION) 44
-
TABLE 10
-
GLOBAL HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 45
-
GLOBAL HALITOSIS TREATMENT MARKET FOR HALIMETER, BY REGION, 2023-2030
-
(USD MILLION) 47
-
GLOBAL HALITOSIS TREATMENT MARKET FOR GAS CHROMATOGRAPHY,
-
BY REGION, 2023-2030 (USD MILLION) 48
-
GLOBAL HALITOSIS TREATMENT
-
MARKET FOR BANA TEST, BY REGION, 2023-2030 (USD MILLION) 48
-
TABLE 14
-
GLOBAL HALITOSIS TREATMENT MARKET FOR B- GALACTOSIDASE ACTIVITY ASSAY, BY REGION,
-
GLOBAL HALITOSIS TREATMENT MARKET
-
FOR OTHER TESTS, BY REGION, 2023-2030 (USD MILLION) 50
-
GLOBAL
-
HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 51
-
TABLE
-
GLOBAL HALITOSIS TREATMENT MARKET FOR ANTACIDS, BY REGION, 2023-2030 (USD MILLION)
-
53
-
GLOBAL HALITOSIS TREATMENT MARKET FOR ANTISEPTICS, BY REGION,
-
GLOBAL HALITOSIS TREATMENT MARKET
-
FOR RANITIDINE, BY REGION, 2023-2030 (USD MILLION) 55
-
GLOBAL
-
HALITOSIS TREATMENT MARKET FOR OTHER TREATMENT, BY REGION, 2023-2030 (USD MILLION)
-
56
-
GLOBAL HALITOSIS TREATMENT MARKET, BY REGION, 2023-2030 (USD
-
MILLION) 57
-
AMERICAS HALITOSIS TREATMENT MARKET, BY COUNTRY,
-
AMERICAS HALITOSIS TREATMENT MARKET,
-
BY TYPE, 2023-2030 (USD MILLION) 60
-
AMERICAS HALITOSIS TREATMENT
-
MARKET, BY INDICATION, 2023-2030 (USD MILLION) 60
-
AMERICAS HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 61
-
TABLE
-
AMERICAS HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 62
-
U.S. HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
-
63
-
U.S. HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030
-
(USD MILLION) 64
-
U.S. HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC
-
TEST, 2023-2030 (USD MILLION) 65
-
U.S. HALITOSIS TREATMENT MARKET,
-
BY TREATMENT, 2023-2030 (USD MILLION) 65
-
CANADA HALITOSIS TREATMENT
-
MARKET, BY TYPE, 2023-2030 (USD MILLION) 66
-
CANADA HALITOSIS
-
TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION) 67
-
TABLE 33
-
CANADA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 68
-
CANADA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD
-
MILLION) 68
-
SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY TYPE,
-
SOUTH AMERICA HALITOSIS TREATMENT
-
MARKET, BY INDICATION, 2023-2030 (USD MILLION) 70
-
SOUTH AMERICA
-
HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 71
-
SOUTH AMERICA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD
-
MILLION) 71
-
EUROPE HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023-2030
-
(USD MILLION) 73
-
EUROPE HALITOSIS TREATMENT MARKET, BY TYPE,
-
EUROPE HALITOSIS TREATMENT MARKET,
-
BY INDICATION, 2023-2030 (USD MILLION) 75
-
EUROPE HALITOSIS TREATMENT
-
MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 76
-
EUROPE
-
HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 76
-
TABLE
-
GERMANY HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 77
-
GERMANY HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION)
-
78
-
GERMANY HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030
-
(USD MILLION) 79
-
GERMANY HALITOSIS TREATMENT MARKET, BY TREATMENT,
-
FRANCE HALITOSIS TREATMENT MARKET,
-
BY TYPE, 2023-2030 (USD MILLION) 80
-
FRANCE HALITOSIS TREATMENT
-
MARKET, BY INDICATION, 2023-2030 (USD MILLION) 81
-
FRANCE HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 82
-
TABLE
-
FRANCE HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 82
-
UK HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
-
83
-
UK HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD
-
MILLION) 84
-
U.K. HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST,
-
UK HALITOSIS TREATMENT MARKET, BY
-
TREATMENT, 2023-2030 (USD MILLION) 85
-
ITALY HALITOSIS TREATMENT
-
MARKET, BY TYPE, 2023-2030 (USD MILLION) 86
-
ITALY HALITOSIS
-
TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION) 87
-
TABLE 58
-
ITALY HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 88
-
ITALY HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD
-
MILLION) 88
-
SPAIN HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030
-
(USD MILLION) 89
-
SPAIN HALITOSIS TREATMENT MARKET, BY INDICATION,
-
SPAIN HALITOSIS TREATMENT MARKET,
-
BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 91
-
SPAIN HALITOSIS
-
TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 91
-
EASTERN
-
EUROPE HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 92
-
EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD
-
MILLION) 93
-
EASTERN EUROPE HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC
-
TEST, 2023-2030 (USD MILLION) 94
-
EASTERN EUROPE HALITOSIS TREATMENT
-
MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 94
-
ASIA PACIFIC
-
HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 96
-
TABLE
-
ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 97
-
ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030
-
(USD MILLION) 98
-
ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY
-
DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 99
-
ASIA PACIFIC HALITOSIS
-
TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 99
-
JAPAN
-
HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 100
-
TABLE
-
JAPAN HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION) 101
-
JAPAN HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030
-
(USD MILLION) 102
-
JAPAN HALITOSIS TREATMENT MARKET, BY TREATMENT,
-
CHINA HALITOSIS TREATMENT MARKET,
-
BY TYPE, 2023-2030 (USD MILLION) 103
-
CHINA HALITOSIS TREATMENT
-
MARKET, BY INDICATION, 2023-2030 (USD MILLION) 104
-
CHINA HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 105
-
TABLE
-
CHINA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 105
-
INDIA HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
-
106
-
INDIA HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030
-
(USD MILLION) 107
-
INDIA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC
-
TEST, 2023-2030 (USD MILLION) 108
-
INDIA HALITOSIS TREATMENT
-
MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 108
-
AUSTRALIA
-
HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 109
-
TABLE
-
AUSTRALIA HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION)
-
110
-
AUSTRALIA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST,
-
AUSTRALIA HALITOSIS TREATMENT MARKET,
-
BY TREATMENT, 2023-2030 (USD MILLION) 111
-
REPUBLIC OF KOREA
-
HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 112
-
TABLE
-
REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030 (USD MILLION)
-
113
-
REPUBLIC OF KOREA HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC
-
TEST, 2023-2030 (USD MILLION) 114
-
REPUBLIC OF KOREA HALITOSIS
-
TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 114
-
TABLE 93
-
REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
-
115
-
REST OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY INDICATION,
-
REST OF ASIA PACIFIC HALITOSIS TREATMENT
-
MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 117
-
REST
-
OF ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION)
-
117
-
MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY
-
COUNTRY, 2023-2030 (USD MILLION) 118
-
MIDDLE EAST & AFRICA
-
HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 119
-
TABLE
-
MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY INDICATION, 2023-2030
-
(USD MILLION) 120
-
MIDDLE EAST & AFRICA HALITOSIS TREATMENT
-
MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 121
-
MIDDLE
-
EAST & AFRICA HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION)
-
121
-
MIDDLE EAST HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030
-
(USD MILLION) 122
-
MIDDLE EAST HALITOSIS TREATMENT MARKET, BY
-
INDICATION, 2023-2030 (USD MILLION) 123
-
MIDDLE EAST HALITOSIS
-
TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 124
-
TABLE
-
MIDDLE EAST HALITOSIS TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION)
-
124
-
AFRICA HALITOSIS TREATMENT MARKET, BY TYPE, 2023-2030 (USD
-
MILLION) 125
-
AFRICA HALITOSIS TREATMENT MARKET, BY INDICATION,
-
AFRICA HALITOSIS TREATMENT MARKET,
-
BY DIAGNOSTIC TEST, 2023-2030 (USD MILLION) 127
-
AFRICA HALITOSIS
-
TREATMENT MARKET, BY TREATMENT, 2023-2030 (USD MILLION) 127
-
TABLE 110
-
ABBOTT: KEY DEVELOPMENTS 133
-
ROWPAR PHARMACEUTICALS, INC.:
-
KEY DEVELOPMENTS 147
-
List of Figures
-
GLOBAL HALITOSIS
-
MARKET, BY TYPE, 2023 (%) 13
-
GLOBAL HALITOSIS MARKET, BY INDICATION,
-
GLOBAL HALITOSIS MARKET, BY DIAGNOSTIC TEST, 2023
-
(%) 14
-
GLOBAL HALITOSIS MARKET, BY TREATMENT, 2023 (%) 15
-
GLOBAL HALITOSIS MARKET, BY REGION, 2023 (%) 16
-
FIGURE
-
GLOBAL HALITOSIS MARKET: MARKET STRUCTURE 19
-
RESEARCH PROCESS
-
20
-
MARKET ASSESMENT: TRAIGULATION APPROACH 21
-
FIGURE
-
GLOBAL HALITOSIS MARKET: FORECAST MODEL 24
-
PORTERS FIVE FORCES
-
MODEL 28
-
VALUE CHAIN: HALITOSIS 30
-
GLOBAL
-
HALITOSIS TREATMENT MARKET, BY TYPE, 2023 & 2030 (USD MILLION) 35
-
FIGURE
-
GLOBAL HALITOSIS TREATMENT MARKET, BY INDICATION, 2023 & 2030 (USD MILLION)
-
39
-
GLOBAL HALITOSIS TREATMENT MARKET, BY DIAGNOSTIC TEST, 2023
-
& 2030 (USD MILLION) 46
-
GLOBAL HALITOSIS TREATMENT MARKET,
-
BY TREATMENT, 2023 & 2030 (USD MILLION) 52
-
GLOBAL HALITOSIS
-
TREATMENT MARKET, BY REGION, 2023 & 2030 (USD MILLION) 58
-
FIGURE
-
AMERICAS HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023 (%) 59
-
FIGURE
-
EUROPE HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023 (%) 74
-
FIGURE
-
ASIA PACIFIC HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023 (%) 97
-
FIGURE
-
MIDDLE EAST & AFRICA HALITOSIS TREATMENT MARKET, BY COUNTRY, 2023 (%) 118
-
GLOBAL HALITOSIS MARKET: COMPETITIVE LANDSCAPE 129
-
FIGURE
-
GLOBAL HALITOSIS MARKET: COMPANY SHARE ANALYSIS 130
-
ABBOTT:
-
RECENT FINANCIALS (USD MILLION) 131
-
ABBOTT: GEOGRAPHICAL REVENUE,
-
ABBOTT: SEGMENTAL REVENUE, 2023 (%) 132
-
ABBOTT: SWOT ANALYSIS 133
-
ALL USA PARTNERS LLC:
-
SWOT ANALYSIS 135
-
ASTRAZENECA: RECENT FINANCIAL 136
-
ASTRAZENECA: OPERATING SEGMENTS 137
-
ASTRAZENECA:
-
GEOGRAPHICAL MIX 137
-
ASTRAZENECA: SWOT ANALYSIS 138
-
COLGATE-PALMOLIVE COMPANY: RECENT FINANCIALS (USD MILLION) 139
-
COLGATE-PALMOLIVE COMPANY: GEOGRAPHICAL REVENUE, 2023 (%) 140
-
COLGATE-PALMOLIVE COMPANY: SEGMENTAL REVENUE, 2023 (%) 140
-
COLGATE-PALMOLIVE COMPANY: SWOT ANALYSIS 141
-
DR.
-
HAROLD KATZ, LLC: SWOT ANALYSIS 143
-
LISTERINE: RECENT FINANCIALS
-
(USD MILLION) 144
-
LISTERINE: GEOGRAPHICAL REVENUE, 2023 (%)
-
145
-
LISTERINE: SEGMENTAL REVENUE, 2023 (%) 145
-
FIGURE
-
LISTERINE: SWOT ANALYSIS 146
-
ROWPAR PHARMACEUTICALS, INC.:
-
SWOT ANALYSIS 148
Leave a Comment